Qi Li
Harbin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Integrative profiling of lactylation reveals prognostic biomarkers and an immunosuppressive niche in acute myeloid leukemia.
Journal: Frontiers in immunology
Published: December 11, 2025
Administering Bifidobacterium pseudolongum With Arsenic Trioxide Attenuates Acute Promyelocytic Leukemia in Mice by Restoring Immune Microenvironment and Intestinal Homeostasis.
Journal: Frontiers in bioscience (Landmark edition)
Published: November 26, 2025
Clinical Characteristics, Molecular Analysis and Survival Outcomes of Patients With Extramedullary Acute Myeloid Leukemia: A Retrospective Single-Center Study.
Journal: Clinical lymphoma, myeloma & leukemia
Published: October 25, 2025
Safety and efficacy of venetoclax-azacitidine combined with low-dose Idarubicin and cytarabine regimens for the treatment of newly diagnosed acute myeloid leukemia patients compared to the standard chemotherapy: a propensity score-matched real-world single-center experience.
Journal: Annals of hematology
Published: March 19, 2025
Efficacy and safety of an HDACi- and HMA-based protocol in adults with acute myeloid leukemia of intermediate- and adverse-risk categories: a retrospective study.
Journal: Hematology (Amsterdam, Netherlands)
Published: June 06, 2023
Expression analysis, clinical significance and potential function of PLXNB2 in acute myeloid leukaemia.
Journal: Molecular biology reports
Published: April 11, 2023
Single-Center Retrospective Clinical Evaluation of Venetoclax Combined with HMAs and Half-Dose CAG for Unfit or Refractory/Relapsed AML.
Journal: OncoTargets and therapy
Published: February 03, 2023
A circular RNA derived from PLXNB2 as a valuable predictor of the prognosis of patients with acute myeloid leukaemia.
Journal: Journal of translational medicine
Published: December 19, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026